In vitro studies confirmed that docetaxel exposure increased the expression of MAOA in multiple prostate cancer cell lines, and inhibition of MAOA enzymatic activity using MAOA inhibitors enhanced the cytotoxicity of docetaxel. This evidence concerns the gene MAOA and prostate carcinoma.